NCT04591431 2023-10-03
ROME
Fondazione per la Medicina Personalizzata
Phase 2 Unknown
Clinical Trials
9 trialsNCT03110484 2022-06-15
Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study
Samsung Medical Center
Phase 2 Unknown
NCT01729481 2017-07-19
ML22774
Ludwig-Maximilians - University of Munich
Phase 2 Unknown
NCT02013089 2016-08-30
GITIC
Sun Yat-sen University
Phase NA Unknown
NCT01608841 2015-02-18
The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib
Taipei Veterans General Hospital, Taiwan
Phase 2 Unknown
NCT00686114 2014-04-29
Concurrent Chemoradiotherapy Containing Paclitaxel&Cisplatin With/Without Tarceva in Locally Advanced Esophageal Cancer
Wenzhou Medical University
Phase 3 Unknown
NCT00566800 2013-09-17
Erlotinib in Treating Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00440167 2012-07-09
Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine
Ludwig-Maximilians - University of Munich
Phase 3 Unknown
NCT00784667 2010-11-30
Dux
Austin Health
Phase 2 Unknown